PL
UTHR icon

Perpetual Ltd’s United Therapeutics UTHR Stock Holding History

Perpetual Ltd’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Sell
704
-513
-42% -$289K 0.01% 374
2026
Q1 		$722K Sell
1,217
-957
-44% -$477K 0.01% 261
2025
Q4 		$1.06M Buy
+2,174
New +$1.01M 0.02% 232
2025
Q1 		– Sell
-1,170
Closed -$413K – 440
2024
Q4 		$413K Buy
1,170
+448
+62% +$165K ﹤0.01% 344
2024
Q3 		$259K Buy
+722
New +$244K ﹤0.01% 384
2024
Q2 		– Sell
-1,178
Closed -$271K – 474
2024
Q1 		$271K Buy
+1,178
New +$266K ﹤0.01% 401

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Perpetual Ltd's UTHR Position: Q2 2026 in Review

Perpetual Ltd reduced its United Therapeutics (UTHR) stake by 42% in Q2 2026, selling an estimated $289K and leaving 704 shares worth $381K. The position accounts for 0.01% of the portfolio, ranked #374.

Perpetual Ltd first reported a position in UTHR in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.06M in Q4 2025. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Perpetual Ltd held 704 shares of United Therapeutics worth $381K as of Q2 2026.
  • Perpetual Ltd sold 513 United Therapeutics shares in Q2 2026, an estimated $289K.
  • United Therapeutics made up 0.01% of Perpetual Ltd's portfolio in Q2 2026, its #374 holding.
  • Perpetual Ltd first reported a position in United Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • Perpetual Ltd's United Therapeutics position peaked at $1.06M in Q4 2025.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.